| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/01.CCM.0000050298.59549.4A |
| P698 | PubMed publication ID | 12576952 |
| P2093 | author name string | Claude Martin | |
| Marc Leone | |||
| Aurélie Bourgoin | |||
| Jacques Albanèse | |||
| Sylvie Cambon | |||
| Myriam Dubuc | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| sepsis | Q183134 | ||
| septic shock | Q1765564 | ||
| P304 | page(s) | 462-467 | |
| P577 | publication date | 2003-02-01 | |
| P1433 | published in | Critical Care Medicine | Q5186605 |
| P1476 | title | Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome | |
| P478 | volume | 31 |
| Q46417621 | A blueprint for a sepsis protocol |
| Q30416983 | Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study |
| Q98170152 | Antibiotic treatment with one single dose of gentamicin at admittance in addition to a β-lactam antibiotic in the treatment of community-acquired bloodstream infection with sepsis |
| Q38198157 | Antimicrobial stewardship of β-lactams in intensive care units |
| Q35537823 | Appropriate empirical antibacterial therapy for nosocomial infections: getting it right the first time |
| Q37636910 | Appropriate use of antimicrobials: the peculiarity of septic patients |
| Q59339920 | Appropriateness of empiric antimicrobial therapy with imipenem/colistin in severe septic patients: observational cohort study |
| Q30756968 | Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials |
| Q33803393 | Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome |
| Q33520432 | Bundled care for septic shock: an analysis of clinical trials |
| Q36774787 | Characteristics and outcomes of anti-infective de-escalation during health care-associated intra-abdominal infections |
| Q37201460 | Clinical sepsis and septic shock--definition, diagnosis and management principles |
| Q43962636 | Clinical spectrum and outcome of critically ill patients suffering from prosthetic joint infections |
| Q49109687 | Colonization status and appropriate antibiotic therapy for nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in an intensive care unit |
| Q36128166 | Concerns of the anesthesiologist: anesthetic induction in severe sepsis or septic shock patients |
| Q35561279 | De-escalation as part of a global strategy of empiric antibiotherapy management. A retrospective study in a medico-surgical intensive care unit |
| Q85337866 | De-escalation in severe sepsis: still an important part of our armamentarium against antimicrobial resistance, of course! |
| Q46744719 | De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study. |
| Q44692768 | De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. |
| Q44019769 | De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial |
| Q61757070 | Diagnose und Therapie der Sepsis |
| Q44754456 | Diagnosis and therapy of sepsis |
| Q41980820 | Does nonadherence to local recommendations for empirical antibiotic therapy on admission to the intensive care unit have an impact on in-hospital mortality? |
| Q44658786 | Early and adequate antibiotic therapy in the treatment of severe sepsis and septic shock |
| Q47155277 | Empirical antibiotic therapy of sepsis in surgical intensive care unit |
| Q90582364 | Evaluation of aminoglycosides utilization in intensive care units of a teaching hospital in southern Iran |
| Q33846503 | Evaluation of early antimicrobial therapy adaptation guided by the BetaLACTA® test: a case-control study |
| Q40385486 | Factors associated with suitability of empiric antibiotic therapy in hospitalized patients with bloodstream infections |
| Q22241905 | Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia |
| Q35091494 | Impact of inactive empiric antimicrobial therapy on inpatient mortality and length of stay. |
| Q55467877 | Improved empirical antibiotic treatment of sepsis after an educational intervention: the ABISS-Edusepsis study. |
| Q34274614 | Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis |
| Q39214678 | Infectiological diagnostic problems in tertiary peritonitis |
| Q37933361 | Life-years gained with meropenem over ciprofloxacin in penicillin-allergic patients with gram-negative bacilli sepsis: results of a probabilistic model. |
| Q83390539 | Management of antimicrobial use in the intensive care unit |
| Q33640559 | Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conference |
| Q33539217 | Microbiogical data, but not procalcitonin improve the accuracy of the clinical pulmonary infection score |
| Q64101593 | Optimization of the treatment with beta-lactam antibiotics in critically ill patients-guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique-SFPT) and the French Society of Anaesth |
| Q37822457 | Overview of antimicrobial therapy in intensive care units |
| Q91940851 | Prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria |
| Q33974292 | Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine |
| Q43535668 | Previous endotracheal aspirate allows guiding the initial treatment of ventilator-associated pneumonia |
| Q36098171 | Prospective evaluation of SeptiFast Multiplex PCR in children with systemic inflammatory response syndrome under antibiotic treatment |
| Q61757039 | Prävention, Diagnose, Therapie und Nachsorge der Sepsis |
| Q51816749 | Risk factors and outcome of Acinetobacter baumanii infection in severe trauma patients. |
| Q35567200 | Strategies of initiation and streamlining of antibiotic therapy in 41 French intensive care units |
| Q37781944 | Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis |
| Q48174077 | The clinical impact of bacteremia on outcomes in elderly patients with pyelonephritis or urinary sepsis: A prospective multicenter study |
| Q26823328 | The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents |
| Q37587025 | The microcirculation as a diagnostic and therapeutic target in sepsis |
| Q46958406 | Translating evidence into practice: the importance of continuing local bacterial surveillance even when national data are available |
| Q34896896 | Treatment of bloodstream infections in ICUs |
| Q47129727 | Update on ventilator-associated pneumonia. |
| Q79285415 | Which therapeutic prospects in the septic syndrome? |
| Q83673248 | [Antibiotic treatment of nosocomial pneumonia] |
| Q75198775 | [Progress in therapy of infection] |
Search more.